The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Murray Richard /ca/ since year 2005.
The trader's CIK number is 1242935.
At the time of this reporting, Murray Richard /ca/ is the CEO and President of Jounce Therapeutics, Inc. .
(stock ticker symbol JNCE).
See this page for all insider trading activities at Jounce Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-09-06||JNCE||Jounce Therapeutics, Inc.||Option Ex||32,000||.48||15,360|
|2018-03-08||JNCE||Jounce Therapeutics, Inc.||Sale||16,334||25.10||409,983|
|2018-03-08||JNCE||Jounce Therapeutics, Inc.||Option Ex||16,334||.48||7,840|
|2018-03-05||JNCE||Jounce Therapeutics, Inc.||Sale||16,334||21.64||353,386|
|2018-03-05||JNCE||Jounce Therapeutics, Inc.||Option Ex||16,334||.48||7,840|
|2008-04-28||PDLI||Protein Design Labs Inc/de||Option Ex||20,000||7.85||157,000|
|2006-03-03||PDLI||Protein Design Labs Inc/de||Option Ex||15,000||10.32||154,740|
|2006-03-06||PDLI||Protein Design Labs Inc/de||Sale||12,673||32.00||405,536|
|2006-03-03||PDLI||Protein Design Labs Inc/de||Sale||2,327||32.02||74,510|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murray Richard /ca/ (CEO and President of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.